State Street’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$218M Sell
2,967,587
-434,349
-13% -$31.9M 0.01% 846
2025
Q1
$389M Sell
3,401,936
-146,416
-4% -$16.7M 0.02% 600
2024
Q4
$179M Buy
3,548,352
+29,089
+0.8% +$1.47M 0.01% 1005
2024
Q3
$163M Buy
3,519,263
+19,893
+0.6% +$921K 0.01% 1046
2024
Q2
$114M Sell
3,499,370
-76,156
-2% -$2.47M 0.01% 1178
2024
Q1
$90.1M Buy
3,575,526
+188,061
+6% +$4.74M ﹤0.01% 1374
2023
Q4
$110M Buy
3,387,465
+244,414
+8% +$7.94M 0.01% 1232
2023
Q3
$85.6M Sell
3,143,051
-23,243
-0.7% -$633K ﹤0.01% 1283
2023
Q2
$70.5M Sell
3,166,294
-124,611
-4% -$2.77M ﹤0.01% 1453
2023
Q1
$71.3M Buy
3,290,905
+92,211
+3% +$2M ﹤0.01% 1412
2022
Q4
$65M Sell
3,198,694
-264,904
-8% -$5.38M ﹤0.01% 1448
2022
Q3
$88.8M Sell
3,463,598
-35,848
-1% -$919K 0.01% 1185
2022
Q2
$83.2M Buy
3,499,446
+89,888
+3% +$2.14M 0.01% 1299
2022
Q1
$76.8M Buy
3,409,558
+101,078
+3% +$2.28M ﹤0.01% 1480
2021
Q4
$65.5M Buy
3,308,480
+35,737
+1% +$708K ﹤0.01% 1618
2021
Q3
$64.4M Sell
3,272,743
-9,129
-0.3% -$180K ﹤0.01% 1616
2021
Q2
$72.2M Buy
3,281,872
+58,915
+2% +$1.3M ﹤0.01% 1563
2021
Q1
$76.7M Sell
3,222,957
-7,475
-0.2% -$178K ﹤0.01% 1435
2020
Q4
$84.5M Buy
3,230,432
+62,341
+2% +$1.63M 0.01% 1272
2020
Q3
$55.1M Sell
3,168,091
-121,102
-4% -$2.11M ﹤0.01% 1387
2020
Q2
$55.3M Buy
3,289,193
+114,590
+4% +$1.93M ﹤0.01% 1398
2020
Q1
$37.7M Buy
3,174,603
+147,082
+5% +$1.75M ﹤0.01% 1431
2019
Q4
$36.6M Buy
3,027,521
+112,000
+4% +$1.36M ﹤0.01% 1732
2019
Q3
$41.2M Sell
2,915,521
-86,666
-3% -$1.23M ﹤0.01% 1564
2019
Q2
$33.5M Sell
3,002,187
-137,531
-4% -$1.53M ﹤0.01% 1748
2019
Q1
$36.9M Buy
3,139,718
+197,367
+7% +$2.32M ﹤0.01% 1630
2018
Q4
$39.3M Sell
2,942,351
-284,635
-9% -$3.8M ﹤0.01% 1509
2018
Q3
$45.2M Buy
3,226,986
+318,429
+11% +$4.46M ﹤0.01% 1596
2018
Q2
$45.7M Sell
2,908,557
-228,147
-7% -$3.59M ﹤0.01% 1553
2018
Q1
$51.6M Buy
3,136,704
+263,711
+9% +$4.34M ﹤0.01% 1406
2017
Q4
$51.9M Buy
2,872,993
+929,689
+48% +$16.8M ﹤0.01% 1408
2017
Q3
$37.5M Sell
1,943,304
-84,709
-4% -$1.63M ﹤0.01% 1574
2017
Q2
$23.9M Buy
2,028,013
+420,139
+26% +$4.96M ﹤0.01% 1858
2017
Q1
$17.6M Buy
1,607,874
+347,808
+28% +$3.81M ﹤0.01% 2034
2016
Q4
$9.15M Buy
1,260,066
+55,533
+5% +$403K ﹤0.01% 2390
2016
Q3
$7.83M Buy
1,204,533
+41,594
+4% +$270K ﹤0.01% 2318
2016
Q2
$6.35M Buy
1,162,939
+260,699
+29% +$1.42M ﹤0.01% 2469
2016
Q1
$4.22M Buy
902,240
+33,449
+4% +$157K ﹤0.01% 2641
2015
Q4
$4.32M Buy
868,791
+17,272
+2% +$85.9K ﹤0.01% 2610
2015
Q3
$3.2M Buy
851,519
+12,622
+2% +$47.4K ﹤0.01% 2763
2015
Q2
$5.04M Sell
838,897
-150,099
-15% -$902K ﹤0.01% 2615
2015
Q1
$5.54M Buy
988,996
+26,707
+3% +$150K ﹤0.01% 2511
2014
Q4
$2.89M Buy
962,289
+4,867
+0.5% +$14.6K ﹤0.01% 2870
2014
Q3
$2.56M Buy
957,422
+48,989
+5% +$131K ﹤0.01% 2880
2014
Q2
$2.54M Buy
908,433
+111,285
+14% +$312K ﹤0.01% 2951
2014
Q1
$3.48M Buy
797,148
+80,458
+11% +$351K ﹤0.01% 2778
2013
Q4
$2.31M Buy
716,690
+21,070
+3% +$67.9K ﹤0.01% 2998
2013
Q3
$1.1M Buy
695,620
+1,892
+0.3% +$3K ﹤0.01% 3232
2013
Q2
$1.2M Buy
+693,728
New +$1.2M ﹤0.01% 3163